A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled Dose-Range Finding Clinical Trial of MK0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin.
Phase of Trial: Phase II
Latest Information Update: 06 Nov 2012
At a glance
- Drugs MK 0941 (Primary) ; Insulin glargine; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacogenomic; Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 31 Aug 2012 Investigational drugs identified as reported by ClinicalTrials.gov.
- 12 Oct 2011 Results published in the Diabetes Care.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History